Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes
Authors:
Open Access
- 14 March 2011
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 164 (3) , 330-336
Abstract
Summary: Anti-neutrophil cytoplasmic autoantibodies (ANCA) are a common feature of systemic vasculitides and have been classified as autoimmune conditions based, in part, on these autoantibodies. ANCA are subdivided further based on their primary target: cytoplasm (c-ANCA) or perinuclear region (p-ANCA). p-ANCAs commonly target myeloperoxidase (MPO), an enzyme with microbicidal and degradative activity. MPO antibodies are non-specific for any single disease and found in a variety of vasculitides, most commonly microscopic polyangiitis. Despite their prevalence, their role in human disease pathogenesis remains undefined. We sought to characterize the sequential antigenic determinants of MPO in vasculitis patients with p-ANCA. Of 68 patients with significant levels of p-ANCA, 12 have significant levels of MPO antibodies and were selected for fine specificity epitope mapping. Sequential antigenic targets, including those containing amino acids (aa) 213–222 (WTPGVKRNGF) and aa 511–522 (RLDNRYQPMEPN), were commonly targeted with a prevalence ranging from 33% to 58%. Subsequent analysis of autoantibody binding to the RLDNRYQPMEPN peptide was assessed using a confirmatory enzyme-linked immunosorbent assay format, with six patients displaying significant binding using this method. Antibodies against this epitope, along with four others (aa 393–402, aa 437–446, aa 479–488 and aa 717–726), were reactive to the heavy chain structure of the MPO protein. One epitope, GSASPMELLS (aa 91–100), was within the pro-peptide structure of MPO. B cell epitope prediction algorithms identified all or part of the seven epitopes defined. These results provide major common human anti-MPO immunodominant antigenic targets which can be used to examine further the potential pathogenic mechanisms for these autoantibodies.Keywords
This publication has 42 references indexed in Scilit:
- Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener's granulomatosisClinical and Experimental Immunology, 2010
- Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitidesAnnals of the Rheumatic Diseases, 2009
- ElliPro: a new structure-based tool for the prediction of antibody epitopesBMC Bioinformatics, 2008
- IgG subclass distribution, affinity of anti‐myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitisNephrology, 2008
- Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody–Associated VasculitisClinical Journal of the American Society of Nephrology, 2008
- An altered immune response to Epstein‐Barr nuclear antigen 1 in pediatric systemic lupus erythematosusArthritis & Rheumatism, 2005
- Difference in antigenic determinant profiles between human and rat myeloperoxidaseClinical and Experimental Immunology, 2003
- The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodiesKidney International, 1999
- Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitisClinical and Experimental Immunology, 1997
- A semi‐empirical method for prediction of antigenic determinants on protein antigensFEBS Letters, 1990